NFKB1 and acute kidney injury: Andrade‐Oliveira et al demonstrated that intraperitoneal injection with SCFAs improved acute kidney injury (AKI) by decreasing inflammatory cytokines and chemokines locally and systemically via suppressing NF‐κB signaling pathway.4